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Background: Poor clinical trial enrollment continues to be pervasive and is especially problematic among young adults
and youth, and among minorities. Efforts to address barriers to enrollment have been predominantly focused on adult
diseased populations. Because older adults may already have established attitudes, it is imperative to identify strategies
that target adolescents and young adults. The purpose of this study was to test the effectiveness of an educational video
on factors related to clinical trial participation among a healthy adolescent and young adult population.
Methods: Participants completed a 49-item pre-test, viewed a 10-min video, and completed a 45-item post-test to
assess changes in attitudes, knowledge, self-efficacy, receptivity to, and intention to participate (primary outcome) in
clinical trials. Descriptive statistics, paired samples t-tests, and Wilcoxon signed-rank tests were conducted.
Results: The final analyses included 935 participants. The mean age was 20.7 years, with almost 70% aged 18 to
20 years. The majority were female (73%), non-Hispanic (92.2%), white (70%), or African American (20%).
Participants indicated a higher intention to participate in a clinical trial (p < 0.0001) and receptivity to hearing
more about a clinical trial (p < 0.0001) after seeing the video. Intention to participate (definitely yes and probably
yes) increased by an absolute 18% (95% confidence interval 15–22%). There were significant improvements in
attitudes, knowledge, and self-efficacy scores for all participants (p < 0.0001).
Conclusions: The results of this study showed strong evidence for the effectiveness of a brief intervention on
factors related to participation in clinical trials. This supports the use of a brief intervention, in a traditional
educational setting, to impact the immediate attitudes, knowledge, self-efficacy, and intention to participate in
clinical trial research among diverse, healthy adolescents and young adults.
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Clinical trials are the backbone of medical treatment de-
velopment and serve as the gold standard by which new
treatments are tested. Yet, poor recruitment plagues the
majority of trials [1], which slows the pace and increases
the cost of medical discoveries. Poor clinical trial enroll-
ment is very common and is a significant challenge
across all types of trials and disease areas [1–4]. Adoles-
cents and young adults have the lowest clinical trial par-
ticipation rates and are least likely to express willingness
to consider being in a clinical trial among all age groups
[5–7]. Furthermore, minorities of all ages are underrep-
resented in clinical trials compared with their population
representation [8–10].
Because reaching adults with broadly disseminated
educational and behavioral interventions about clinical
trials has practical limitations, and because some adults
may already have established attitudes including long-
standing distrust of the medical system [11], it is impera-
tive to identify effective strategies that target adolescents
and young adults. High school and college students are
on the cusp of adult decision-making age, are easily
reachable in an educational setting, and have had fewer
opportunities to develop negative attitudes about med-
ical research. Decades of research have established the
influence of early attitude formation on attitudes and be-
haviors throughout the lifespan. Child development and
educational psychology research has consistently found
that attitudes formed during adolescence persist into
adulthood [12–14] and influence subsequent adult be-
havior, including health behaviors such as diet and exer-
cise [14–16]. Targets to address should include
knowledge about clinical trials (the most frequently re-
ported barrier to awareness of clinical trials) and mistrust
of research and the medical system (the most frequently
reported barrier to acceptance of participation to clinical
trials) [13]. Irrespective of level of education, patients of-
fered enrollment into trials struggle with the concept of
randomized controlled trials, which suggests that general
education of the public about trials is needed [17].
The importance of addressing clinical trial participation
among adolescents and young adults is twofold: (1) to pre-
pare them for more immediate clinical trial opportunities
that may present, given their already low participation
rates and (2) to instill an openness to clinical trial partici-
pation that will survive into later adulthood when most
trial opportunities are likely to occur. This generates the
need to identify predictors of both current and future be-
havior. The theory of planned Behavior (TPB) posits that
behavioral intention is the best predictor of future behav-
ior. The theory aims to predict behavioral intention by
identifying an individual’s attitudes, subjective norms, and
perceived behavioral control (self-efficacy) [18]. TPB has
been widely applied to a multitude of health behaviors inadolescent and young adult populations [19, 20]. Proper
application of the model in educational and behavioral in-
terventions requires an understanding of the behavior in
the study population [21].
The purpose of this study was, therefore, to test the ef-
fectiveness of an existing video regarding clinical trial par-
ticipation on intention, knowledge, attitudes, self-efficacy,
and receptivity to participate in an adolescent and young
adult population. If brief, effective strategies were avail-
able, widespread educational and behavioral efforts could
be undertaken that could ultimately impact future na-
tional clinical trial enrollment rates.
Methods
Undergraduate students at a large public university in
southeast Michigan 18 to 40 years of age were offered par-
ticipation in the study. As a school of opportunity, the
18,000 undergraduate students represent a greater propor-
tion of low-income, part-time, and first-generation under-
graduate students than the surrounding institutions.
Minorities constitute 30% of the student body while 59%
are female. Recruitment was focused on first-year students
in introductory general education courses. The effective-
ness of the brief intervention was tested with an anonym-
ous pre-test/post-test design. The study was implemented
in person during regularly scheduled classes, and electron-
ically through on-line classes or through on-line extra
credit opportunities offered within a variety of programs.
The study was approved by the University’s Human Sub-
jects Review committee and considered exempt.
Procedures and data collection
Participants were instructed to complete a 49-item
pre-test survey. This consisted of four items to assess
participant demographics (age, gender, race, and ethni-
city) and a pre-existing set of questions in five domains
related to clinical trials: attitudes (20 items), knowledge
(13 items), perceived ability/self-efficacy (9 items), recep-
tivity to hear about (1 item), and intention to participate
in (1 item) clinical trials [22]. This survey was originally
developed to address cancer clinical trials and was previ-
ously adapted to include more generic language for pre-
sumably healthy individuals [23]. To establish internal
consistency of the instrument for a healthy, adolescent
and young adult sample, Cronbach’s alpha coefficients
were calculated for the 20 attitude and 9 self-efficacy
items and were acceptable at 0.84 and 0.91, respectively.
One additional question was included to assess willing-
ness to participate in a hypothetical clinical trial (see the
Appendix for vignette language).
Upon completion of the pre-test, participants were
shown (in person), or directed to (imbedded in the elec-
tronic survey), a 10-min video entitled “You’ve Got the
Power” created by the National Medical Association as
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and Awareness of Clinical Trials) [24]. The goal of the
video is to increase awareness, knowledge, and participa-
tion of African American adults in biomedical research.
Although specifically culturally targeted toward African
Americans, the information provided in the video is rele-
vant for all individuals. Immediately after viewing the
video, participants completed the 45-item post-test (the
same items as the pre-test with the exception of the
items on demographics). Each session took approxi-
mately 30 min to conduct.
Outcomes and statistical analysis
The primary outcome of the study was intent to partici-
pate in clinical trial research. Secondary outcomes in-
cluded knowledge, attitudes, self-efficacy, and receptivity
regarding clinical trials and clinical trial participation.
Participation in a specific hypothetical research trial was
investigated as an exploratory outcome.
Descriptive statistics were calculated for the group
overall, and by racial and gender subgroups. Subgroup
analyses for primary, secondary, and exploratory out-
comes were limited to white and African American, fe-
male and male, due to the low number of participants in
other categories. Intention to participate in and receptiv-
ity to hearing more information about clinical trials were
each assessed with a single item utilizing a five-point
Likert response ranging from “definitely yes” (1) to “def-
initely no” (5). As these items were measured on an or-
dinal scale, Wilcoxon signed-rank tests were performed
to assess differences in pre- and post-test responses. Re-
sponses were also dichotomized into “yes” (“definitely
yes” and “probably yes”) and “no” (“unsure,” “probably
no,” and “definitely no”), and differences in proportions
intent to participate and receptive to hear more about
clinical trials between the post-test and pre-test were
calculated along with adjusted Wald 95% confidence in-
tervals (CIs).
Knowledge was measured with 13 items with response
choices “true,” “false,” and “don’t know.” The knowledge
score was calculated as a percentage of correct answers.
Attitudes toward clinical trials (positive and negative)
were assessed with 20 items, with response choices ran-
ging from “strongly agree” (1) to “strongly disagree” (5).
Reversed items were recoded, and a mean scale score
was calculated with a range of 1 to 5, with 1 being a
more negative attitude about clinical trials. Self-efficacy
regarding participants’ perceived ability to make an in-
formed decision about participating in a clinical trial was
assessed with 9 items, with response choices ranging
from “strongly agree” (1) to “strongly disagree” (5). The
self-efficacy mean scale score was calculated with a
range of 1 to 5, with 1 indicating higher self-efficacy.
Missing values were minimal for the attitude andself-efficacy items and were replaced with the mean value
of completed items only if at least 90% of items were com-
pleted. Mean differences in scores from pre-test to
post-test were calculated for knowledge, attitude, and
self-efficacy and compared using paired-samples t-tests.
Participation in a hypothetical trial was measured with
a single-item Likert response ranging from “very un-
likely” (1) to “very likely” (5). Prior to being asked this
question, participants were presented with a hypothetical
scenario (see the Appendix). Wilcoxon signed-rank tests
were performed to assess differences in pre- and
post-test responses. Responses were also dichotomized
into “yes” (“very likely” and “somewhat likely”) and “no”
(“uncertain,” “somewhat unlikely,” and “very unlikely”),
and the difference between the proportion likely to en-
roll at post- and pre-test was calculated along with ad-
justed Wald 95% CIs. Further analysis was conducted to
explore the relationship with post-test responses for par-
ticipant intention to participate in a clinical trial and ac-
tual agreement to participate in the hypothetical trial
scenario. The intention item was recoded so that higher
responses indicated greater intent to participate. Signifi-
cance for all analyses was set at 0.05. Analyses were con-
ducted using IBM SPSS 24.0 for Windows, TIBCO
Spotfire S+ 8.1 for Windows, and R 3.2.0.Results
Sample and participant characteristics
Of the 1048 participants, 276 submitted print surveys
and the remainder were submitted electronically. Of the
submitted surveys, 20 participants were eliminated for
not being within the 18–40 age range, and 17 for miss-
ing the pre-test or the post-test. A question was asked of
those who took the test electronically as to whether they
watched the entire video. Respondents answering “no”
were eliminated (n = 86), leaving n = 935 available for
analysis. The mean age of the sample was 20.7 years
(standard deviation 3.69 years), with almost 70% being
between 18 and 20 years of age and 96% under the age
of 30 (Table 1). The majority of respondents were female
(73%) and non-Hispanic (92%). Respondents identifying
their race as white comprised 70% of the sample while
African Americans accounted for 20%.Primary outcome
Participants indicated a higher level of intention to par-
ticipate (49.0% to 67.9%) in a clinical trial after seeing
the video (Z = −8.70, p < 0.0001). This result was
consistent both among men and women and among
African Americans and whites (p < 0.0001; Table 2).
Similarly, the proportion with intent to participate was
higher in the post-test (49% vs 68%, difference = 18%;
95% CI 15–22%).
Table 1 Baseline characteristics of study sample
Percentage Number





Race (n = 929)
White 69.6 647
African American 20.3 189
American Indian/Alaskan Native 0.3 3
Asian 3.1 29
Native Hawaiian/Other Pacific Islander 0.2 2
More than one race 6.4 59
Ethnicity (n = 915)
Of Hispanic origin 7.8 71
Not of Hispanic origin 92.2 844
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Participants indicated significantly higher receptivity to
hearing more about a clinical trial after watching the
video (Z = −8.415, p < 0.0001). Significant increases in re-
ceptivity were found both among men and women andTable 2 Pre- and post-test receptivity, intention, and likelihood of p
Pre-test Post-tes
n Median IQR n
Receptivity*
Total sample 931 2 1.00, 2.00 933
White 646 2 1.00, 2.00 646
African American 187 2 1.00, 3.00 189
Intention*
Total sample 930 3 2.00, 3.00 932
White 645 3 2.00, 3.00 646
African American 187 2 2.00, 3.00 188
Participate in hypothetical trial*
Total sample 930 3 2.00, 4.00 929
White 645 3 2.00, 4.00 644
African American 187 3 2.00, 4.00 187
CI confidence interval, IQR interquartile range
*Lower scores indicate greater receptivity to hearing more about a relevant clinical
hypothetical clinical trial
**Proportion receptive to hearing more about clinical trials, intent to participate, an
dichotomous post- and pre-test values along with adjusted Wald 95% confidence in
***From Wilcoxon signed-rank test applied to pre-test and post-test comparisonamong African Americans and whites (p < 0.0001;
Table 2). Similarly, the proportion receptive to hearing
more about clinical trials was higher in the post-test
(82% vs 89%, difference = 6%; 95% CI 3–8%).
Comparison of mean pre- and post-test scores for
knowledge, attitude, and self-efficacy are presented in
Table 3. For all participants, there were significant im-
provements in mean pre- and post-test scores for know-
ledge (t(933) = 16.27, p < 0.0001), attitude (t(931) = 16.51,
p < 0.0001), and self-efficacy (t(930) = 16.17, p < 0.0001).
Significant increases in knowledge (t(681) = 13.88 and
t(244) = 8.24), positive attitudes (t(679) = 13.93 and
t(244) = 8.82), and self-efficacy (t(679) = 15.07 and
(t(243) = 6.25) were identified for female and male
participants, respectively (all p < 0.0001). Significant
positive differences in knowledge, attitude, and
self-efficacy between pre- and post-test scores were
identified for both white and African American par-
ticipants as well (all p < 0.0001; Table 3).
Exploratory outcome
When presented with a hypothetical scenario, participants
were more likely to agree to be in the trial after viewing
the video, as a whole, both among men and women and
among African Americans and whites (p < 0.0001; Table 2).
The proportion likely to enroll in the hypothetical trial
was higher in the post-test (40% vs 56%, difference = 15%;
95% CI: 12–18%). Responses to the intention to partici-
pate question (primary outcome) and the response to the
hypothetical trial scenario (both post-test) were associated
(Z = − 15.79, p < 0.001; Table 4).articipating in clinical trials
t Difference in
proportions** (95% CI)Median IQR p***
1 1.00, 2.00 0.06 (0.03, 0.08) < 0.0001
1 1.00, 2.00 0.05 (0.02, 0.07) < 0.0001
2 1.00, 2.00 0.11 (0.04, 0.18) 0.02
2 2.00, 3.00 0.18 (0.15, 0.22) < 0.0001
2 2.00, 3.00 0.20 (0.16, 0.24) < 0.0001
2 2.00, 3.00 0.13 (0.05, 0.22) 0.03
4 2.00, 4.00 0.15 (0.12, 0.18) < 0.0001
4 3.00, 4.00 0.14 (0.10, 0.17) < 0.0001
3 2.00, 4.00 0.16 (0.08, 0.23) < 0.0001
trial, greater intention to participate, and lower likelihood of participation in a
d likely to enroll in a hypothetical clinical trial: difference between
tervals
Table 3 Pre- and post-test scale scores and their comparisons, for knowledge, attitude, and self-efficacy: all participants and among
racial subgroups
n Pre-test Post-test Mean difference p**
mean (SD) mean (SD) (95% CI)
All participants
Knowledge* 934 58.03 (20.47) 68.47 (19.16) 10.44 (9.18, 11.70) < 0.0001
Attitude* 932 3.16 (0.42) 3.41 (0.54) 0.25 (0.23, 0.28) < 0.0001
Self-Efficacy* 931 2.05 (0.62) 1.77 (0.69) −0.28 (− 0.25, − 0.31) < 0.0001
Whites
Knowledge* 647 61.12 (18.58) 71.21 (17.46) 10.09 (8.69, 11.50) < 0.0001
Attitude* 647 3.20 (0.42) 3.46 (0.52) 0.26 (0.23, 0.30) < 0.0001
Self-Efficacy* 647 2.02 (0.58) 1.72 (0.67) −0.30 (− 0.26, − 0.34) < 0.0001
African Americans
Knowledge* 189 49.65 (23.21) 62.07 (20.52) 12.41 (9.08, 15.75) < 0.0001
Attitude* 187 3.06 (0.37) 3.23 (0.57) 0.16 (0.09, 0.24) < 0.0001
Self-Efficacy* 186 2.11 (0.67) 1.92 (0.70) −0.20 (− 0.12, − 0.28) < 0.0001
CI confidence interval, SD standard deviation
*Higher scores indicate greater knowledge, more favorable attitude, and lower self-efficacy
**From Wilcoxon signed-rank test applied to pre-test and post-test comparison
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This single-group pre-test/post-test intervention shows
strong evidence for the effectiveness of a brief video
on factors related to participation in clinical trial re-
search in an adolescent and young adult population.
The impact of the intervention on the primary out-
come was evidenced by significant increases in
intention to participate in clinical trial research in gen-
eral, and indirectly supported by the significant in-
crease in intent to participate in the specific trial
described in the hypothetical scenario. Secondary out-
come measures of knowledge, attitude, self-efficacy re-
garding clinical trials, and receptivity to hearing more
about clinical trials also showed significant increases
from pre-test to post-test scores.
Previous studies have shown that brief educational
interventions can be effective in increasing know-
ledge of clinical trials [25, 26]. Research has also
demonstrated that brief educational efforts canTable 4 Intention to participate by hypothetical trial participation cr
Participate in hypothetica
Very unlikely Som
Intention to participate Definitely no 6 0
Probably no 12 19
Unsure 25 36
Probably yes 32 76
Definitely yes 13 15
Wilcoxon signed-rank test (Z = −15.79, p < 0.0001)impact attitudes and willingness to participate in
clinical trial research [22, 27]. However, previous
studies have focused almost exclusively on adult can-
cer patient populations. To our knowledge, this is
the first study to explore the effectiveness of a brief
video intervention on factors related to hypothetical
clinical trial participation in a healthy adolescent
and young adult population in a traditional educa-
tional setting. Furthermore, the results of this study
show the effectiveness of a culturally targeted inter-
vention among young African Americans. This is
particularly relevant given the documented differ-
ences in attitudes and participation rates in clinical
trials between African American and non-Hispanic
white patient populations [28]. The study also sup-
ports the effectiveness of this intervention in the
majority population, since there was not a large
nominal difference between groups, despite the racial
targeting of the video. This supports a cost-savingoss-tabulation
l trial
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towards a higher risk minority population that will
also be effective in the majority population.
Although we were unable to validate behavioral intent
against actual enrollment, we did assess the association
between behavioral intent to enroll in a trial and re-
sponse to enrollment in a hypothetical trial. These two
were highly associated. The benefits of addressing the
topic of clinical trials in a presumably healthy population
are vast, but application to this population does preclude
testing the effects of the intervention on enrollment into
an actual clinical trial for a disease state relevant to the
individual participants.
Limitations of this study include the use of a video
designed for an African American adult population.
Although those who participated electronically were
asked a question to determine whether they watched
the entire video, we were not able to determine the
level of engagement with the video for electronic or
face-to-face participants. However, the increase in
post-test knowledge helps validate participant engage-
ment. Furthermore, although small in number, those
who participated electronically and indicated they did
not watch the video were excluded from the analysis.
This may have contributed to a slight over-estimate
of the effectiveness of the intervention. It is unclear
from this brief study as to the durability of the results
and how well intention to participate in clinical trial
research will translate to future real-world scenarios if
and when the individual were to become ill and were
offered enrollment in a clinical trial. Generalizability
is limited due to the use of a single university with a
mostly regional population as the sample. Finally, this
single-group pre-test/post-test design lacked a control
group and thus, has limited external validity. The im-
mediacy of the post-test should mitigate this some-
what, however.Conclusions
The results of this study support the use of a brief inter-
vention, designed for a general African American adult
population, in a traditional educational setting to impact
the immediate attitudes, knowledge, self-efficacy, and
intention to participate in clinical trial research among
diverse, healthy late adolescents and young adults. The
next steps should include the development and longitu-
dinal testing of an age-appropriate, culturally relevant
intervention in a younger adolescent population in an
educational setting. If such an approach were deemed ef-
fective, widescale dissemination through a program em-
bedded in the high school curriculum could influence
schoolchildren nationwide and ultimately significantly
impact clinical trial participation for years to come.Appendix
Pretend you have a condition called asthma (“az-ma”).
This causes problems with breathing. You miss school,
sports, and social things about 5 days a month because
of your breathing. You already use inhalers and are
followed by a doctor. Because your asthma is still a
problem for you, your doctor asks if you want to be in a
clinical trial. Here’s more information: The trial com-
pares a new pill to a “dummy pill” called a “placebo” (pill
that has no action). The study will test whether the new
pill helps teens with asthma. Small studies have sug-
gested that the new pill may be helpful. But, there may
be side effects. Few people who take the new pill get
some type of infection. This infection may require medi-
cine to treat it. Sometimes the infection can be serious.
A computer will assign you to get either the new pill or
the dummy pill. You have equal chances of getting the
new pill and the dummy pill – like flipping a coin. You
and your doctor won’t know which pill you are using.
They both look the same. You will take the pill once a
day for 6 months. You will keep track of the days you
miss activities because of your breathing. You will turn
this information in at your doctor visits.
How likely would you be to be in this trial? Very un-
likely, Somewhat unlikely, Uncertain, Somewhat likely,
Very likely.
Abbreviations
CI: Confidence interval; IMPACT: Increase Minority Participation and
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